G70.01

Myasthenia gravis with (acute) exacerbation

Myasthenia gravis with (acute) exacerbation represents a significant worsening of symptoms in a patient with myasthenia gravis (MG), a chronic autoimmune neuromuscular disorder. This condition occurs when the body's immune system mistakenly produces antibodies that block or destroy acetylcholine receptors at the neuromuscular junction, preventing nerve impulses from triggering muscle contractions. An 'acute exacerbation' is a clinical state where muscle weakness becomes severe enough to compromise vital functions or significantly impair daily activities, often serving as a precursor to a myasthenic crisis where respiratory failure may occur. Exacerbations can be triggered by infections, surgery, emotional stress, pregnancy, or certain medications that interfere with neuromuscular transmission. Management typically requires hospitalization for intensive therapy, such as intravenous immunoglobulin (IVIG) or plasmapheresis, alongside adjustment of immunosuppressive or acetylcholinesterase inhibitor medications.

Clinical Symptoms

Severe or worsening muscle weakness that fluctuates throughout the day
Ptosis (drooping of one or both eyelids)
Diplopia (double vision) that worsens with sustained gaze
Dysarthria (slurred or impaired speech)
Dysphagia (difficulty swallowing or frequent choking)
Shortness of breath (dyspnea) at rest or with minimal exertion
Weakness in the neck muscles causing the head to droop
Significant proximal limb weakness making it difficult to climb stairs or lift arms
Weakened cough reflex
Nasal-sounding speech due to palatal weakness
Generalized fatigue that improves with rest

Common Causes

Autoimmune destruction of nicotinic acetylcholine receptors (AChR) at the post-synaptic neuromuscular junction
Presence of muscle-specific receptor tyrosine kinase (MuSK) antibodies
Thymic hyperplasia or thymoma (tumors of the thymus gland)
Acute viral or bacterial infections (most common trigger for exacerbation)
Emotional or physical stress
Post-surgical recovery or trauma
Rapid tapering of immunosuppressive medications
Adverse reactions to medications such as fluoroquinolones, aminoglycosides, beta-blockers, or magnesium salts
Thyroid dysfunction (hyperthyroidism or hypothyroidism)
Pregnancy or postpartum hormonal shifts

Documentation & Coding Tips

Explicitly document the clinical evidence of an acute worsening of symptoms to justify the use of G70.01 over G70.00. An exacerbation is defined as a significant increase in muscular weakness or the appearance of new symptoms like respiratory distress or bulbar weakness.

Example: Patient with established generalized myasthenia gravis presents with a 3-day history of progressive dysphagia and dyspnea on exertion. Examination reveals increased bilateral ptosis and 3/5 strength in proximal limb muscles, compared to 4/5 at baseline. This constitutes an acute exacerbation of G70.01. Management includes admission for IVIG and adjustment of pyridostigmine. HCC 78 is captured via documentation of chronic neuromuscular disease with acute worsening.

Billing Focus: Documentation must specify the acute nature of the worsening to support G70.01. Baseline status should be contrasted with current acute status to demonstrate medical necessity for higher intensity care.

Distinguish between a standard exacerbation and a myasthenic crisis. While G70.01 is used for both, the documentation of respiratory failure as a secondary code is vital for complete clinical representation.

Example: The patient is experiencing a myasthenic crisis, manifested as an acute exacerbation (G70.01) with associated acute respiratory failure (J96.00). Forced vital capacity (FVC) is less than 1 liter. Intubation performed. The acuity of the exacerbation directly influences the MS-DRG assignment for hospital billing.

Billing Focus: Identify specific symptoms of crisis such as respiratory failure or the need for mechanical ventilation. This supports the use of higher-level E/M codes or critical care codes (99291).

Specify the antibody status if known, as this influences the long-term prognosis and treatment path, even though it does not change the primary ICD-10 code for the exacerbation itself.

Example: Known MuSK-antibody positive myasthenia gravis currently in acute exacerbation (G70.01). Patient presents with severe bulbar weakness and neck extensor fatigue. Given the MuSK-positive status, the exacerbation is treated with plasmapheresis rather than IVIG due to historical poor response to the latter. Documentation of the specific antibody type supports medical necessity for specific immunosuppressive therapies.

Billing Focus: Include antibody findings (AChR, MuSK, or LRP4) to support the complexity of the diagnostic reasoning and management plan for high-level E/M services.

Identify and document the trigger for the exacerbation, such as infection, medication changes, or post-operative stress, to provide a complete clinical picture.

Example: Patient with generalized myasthenia gravis experiencing acute exacerbation (G70.01) secondary to community-acquired pneumonia (J18.9). The exacerbation was likely precipitated by the physiological stress of the infection and the recent administration of magnesium in the ED. Documentation of the inciting cause is essential for risk adjustment and care coordination.

Billing Focus: Linking the exacerbation to a trigger (like an infection) allows for the coding of multiple conditions, increasing the complexity level of the encounter.

Clearly state the presence of bulbar symptoms like dysphagia or dysarthria, as these are critical indicators of severity within an exacerbation episode.

Example: Acute exacerbation of myasthenia gravis (G70.01) characterized by new-onset severe dysphagia and nasal speech. Bedside swallow evaluation positive for aspiration risk. Patient requires NPO status and placement of a temporary nasogastric tube for nutrition and medication administration. This level of impairment necessitates inpatient level of care and high-complexity medical decision making.

Billing Focus: Bulbar symptoms often justify the medical necessity for speech therapy (92526) and nutritional support codes alongside the primary diagnosis.

Relevant CPT Codes

99214 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a moderate level of medical decision making
Typically used for management of an acute exacerbation that does not yet require hospitalization but involves medication adjustments.
99215 - Office or other outpatient visit for the evaluation and management of an established patient, which requires a high level of medical decision making
Appropriate for severe exacerbations where the physician must decide between aggressive outpatient treatment or immediate hospital admission.
95911 - Nerve conduction studies; 7-8 studies
Repetitive nerve stimulation is a standard test to confirm MG during an exacerbation if not previously documented.
95886 - Needle electromyography, each extremity, with needle electromyography of cranial nerve supplied muscle(s) done with nerve conduction, amplitude and latency/velocity study
Used to assess for primary muscle disease versus neuromuscular junction disorders like MG.
36514 - Therapeutic apheresis; for plasma pheresis
A first-line treatment for acute MG exacerbation or crisis to rapidly remove AChR or MuSK antibodies.
96413 - Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
Used for the infusion of IVIG or monoclonal antibodies like eculizumab used in MG exacerbation management.
94010 - Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation
Crucial for monitoring respiratory involvement (FVC/NIF) during an exacerbation to prevent crisis.
99204 - Office or other outpatient visit for the evaluation and management of a new patient, which requires a moderate level of medical decision making
Used when a patient with a known diagnosis but new to a specific neurologist presents in exacerbation.
99223 - Initial hospital care, per day, for the evaluation and management of a patient, which requires a high level of medical decision making
The standard code for admitting a patient in myasthenic crisis or severe exacerbation.
99291 - Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes
Applied when MG exacerbation leads to acute respiratory failure requiring intensive monitoring and intervention.